After treating osteosarcoma cells with cisplatin, a widely used anticancer drug, it induces the overexpression of GFRα1, which promotes autophagy to lead to enhanced osteosarcoma cell survival via the SRC-AMPK signaling axis. This evidence concerns the gene SRC and osteosarcoma.